HSP90B2P and non-Hodgkin lymphoma: Therefore, further studies should explore what happens on the level of individual HSP members in different subtypes of HL and NHL lymphoma and whether specific blocking of a particular homolog and, hence, its client and co-chaperone network, will be more advantageous for the lymphoma treatment.